HIGH-RISK PROSTATE CANCER
Clinical trials for HIGH-RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising prostate cancer combo trial pulled before it began
Disease control TerminatedThis study aimed to test a new treatment for men with high-risk prostate cancer who cannot have surgery. The plan was to combine three experimental drugs with radiation therapy to see how well they work together and if they are safe. However, the study was withdrawn before enroll…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
New immunotherapy cocktail aims to fight High-Risk prostate cancer before and after surgery
Disease control TerminatedThis study tested a combination of three immunotherapy drugs (N-803, ETBX-071, and M-CENK) given before and after prostate removal surgery in men with high-risk prostate cancer. The goal was to see if this approach could delay cancer recurrence and improve safety. However, the tr…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Double scan strategy may sharpen prostate cancer staging
Knowledge-focused OngoingThis study looks at whether combining PSMA-PET/CT and MRI scans can more accurately stage prostate cancer in men with intermediate- or high-risk disease. Researchers will compare scan results with tissue samples from 600 men who had their prostate removed. The goal is to improve …
Matched conditions: HIGH-RISK PROSTATE CANCER
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC